Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2024-10-10 00:00:00 ET · period of report 2024-10-09 · accession 0001517026-24-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-10-10 | 2024-10-09 | MYGN | Verratti Mark | Chief Commercial Off | F - Tax | $24.37 | -8,363 | 294.3K | -3% | -$203.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-09 | F | D | 5,004 | $24.37 | 289,277 | D | — | — | (F2) Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 9, 2024. |
| 2 | Common | Common Stock | 2024-10-09 | F | D | 3,359 | $24.37 | 294,281 | D | — | — | (F1) Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 9, 2024. |